1-(3-amino-benzo[d]isoxazol-5-yl)-6-(2'-dimethylaminomethyl-biphenyl-4-yl)-3,5-dimethyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one

ID: ALA213865

PubChem CID: 16046152

Max Phase: Preclinical

Molecular Formula: C29H27N7O2

Molecular Weight: 505.58

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nn(-c2ccc3onc(N)c3c2)c2c(=O)n(-c3ccc(-c4ccccc4CN(C)C)cc3)c(C)nc12

Standard InChI:  InChI=1S/C29H27N7O2/c1-17-26-27(36(32-17)22-13-14-25-24(15-22)28(30)33-38-25)29(37)35(18(2)31-26)21-11-9-19(10-12-21)23-8-6-5-7-20(23)16-34(3)4/h5-15H,16H2,1-4H3,(H2,30,33)

Standard InChI Key:  HSCKUOWMBQOWFF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   -0.0677   -3.3873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7179   -3.6408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8854   -4.4461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6703   -4.6997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2836   -4.1457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1067   -3.3350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3221   -3.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7928   -5.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940   -6.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3646   -5.5510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0804   -5.1416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0833   -4.3157    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5002   -3.0477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7506   -3.8354    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7491   -6.9339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3617   -6.3821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0757   -6.7954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9018   -7.6022    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0808   -7.6847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0582   -6.7612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6734   -3.0439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4187   -3.8274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6144   -3.9972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3236   -2.5991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1273   -2.4331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3578   -4.7819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9903   -2.3820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0651   -4.3964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2384   -5.2048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0237   -5.4573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6362   -4.9025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4583   -4.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6734   -3.8432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4967   -3.0367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1069   -2.4804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8935   -2.7307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9301   -1.6740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2272   -1.9841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 15  2  0
  4  5  2  0
 15 20  1  0
 16 10  2  0
  2  3  2  0
 21 22  2  0
 10 11  1  0
 22 23  1  0
 23  1  1  0
 11  8  2  0
  1 24  1  0
  5  6  1  0
 24 25  2  0
 25 21  1  0
  1  2  1  0
 23 26  2  0
  6  7  2  0
 13 27  1  0
 12 22  1  0
 21 13  1  0
 28 29  2  0
 13 14  2  0
 29 30  1  0
 14 12  1  0
 30 31  2  0
 11 12  1  0
 31 32  1  0
 16 17  1  0
 32 33  2  0
 33 28  1  0
  5 28  1  0
  7  2  1  0
 33 34  1  0
  3  4  1  0
 34 35  1  0
 35 36  1  0
  8  9  1  0
 35 37  1  0
  9 17  2  0
 24 38  1  0
M  END

Associated Targets(Human)

F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTRB1 Tchem Beta-chymotrypsin (261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRSS1 Tclin Trypsin (2137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLAT Tclin Tissue-type plasminogen activator (1057 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F9 Tchem Coagulation factor IX (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PROC Tchem Vitamin K-dependent protein C (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F7 Tchem Coagulation factor VII/tissue factor (740 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin and coagulation factor X (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F9 Tchem Coagulation factor IX and X (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor VII and X (116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KLKB1 Tclin Coagulation factor X and plasma kallikrein (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F10 Coagulation factor X (318 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oryctolagus cuniculus (11301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 505.58Molecular Weight (Monoisotopic): 505.2226AlogP: 4.64#Rotatable Bonds: 5
Polar Surface Area: 108.00Molecular Species: BASEHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.34CX LogP: 3.53CX LogD: 1.60
Aromatic Rings: 6Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -1.37

References

1. Li YL, Fevig JM, Cacciola J, Buriak J, Rossi KA, Jona J, Knabb RM, Luettgen JM, Wong PC, Bai SA, Wexler RR, Lam PY..  (2006)  Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa.,  16  (19): [PMID:16870435] [10.1016/j.bmcl.2006.07.002]

Source